SOLUTION Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO), has signed an exclusive ...

Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The HPV9 vaccine is designed to protect against nine strains of Human Papillomavirus, including those linked to cervical, ...

Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

Biological E. to produce Recbio's HPV9 vaccine in India, expanding global access to cervical cancer prevention.

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

The scientists have developed a therapeutic vaccine based on a recombinant protein called Terah-7, which is capable of stimulating the immune system to fight cancer caused by HPV. The theme of ...

OB/Gyn > Cervical Cancer Therapeutic HPV Vaccine Effective in Reducing Precancerous Cervical Lesions — 17 of 18 patients had reduction in CIN3 lesion size, half had histopathological complete ...